Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 9Neoplasms, Hormone-Dependent 3Carcinoma, Lobular 3Carcinoma, Ductal, Breast 3Prostatic Neoplasms 2Fractures, Bone 2Prostatic Intraepithelial Neoplasia 1Precancerous Conditions 1Osteoporosis 1Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Zoledronic Acid 8Vitamin D 6Risedronic Acid 6Cholecalciferol 4Calcium Carbonate 4Alendronate 4Letrozole 3Denosumab 3Calcium 3Absorptiometry, Photon 3Calcium Gluconate 2Toremifene 1Spectrum Analysis 1Radiotherapy 1Progestins 1Ibandronic Acid 1Hormone Replacement Therapy 1Goserelin 1Gonadotropin-Releasing Hormone 1Geritol 1Estrogens 1Estrogen Replacement Therapy 1Estrogen Antagonists 1Estradiol 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium Citrate 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Osteoporosis × Toremifene × Clear all
NCT00129142 2013-11-15

Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy

GTx

Phase 3 Completed
1,200 enrolled
Genitourinary

Bone Diseases, Metabolic, Osteoporosis, Prostatic Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡